These outcomes follow directly from GLP-1 physiology (Mller et al., 2019), which is why these medications require physician supervision rather than self-direction
Steven Batash, MD, is a gastroenterologist and leading physician at the Batash Endoscopic Weight Loss Center
During breaks from semaglutide or while switching between medications , a supplement providing mild metabolic support could theoretically help maintain some momentum
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for managing type 2 diabetes mellitus (under brand names Ozempic and Rybelsus) and chronic weight management (Wegovy)
We identify the biological drivers of weight gain, including insulin resistance, hormonal imbalance, inflammation, and metabolic slowdown, using comprehensive laboratory testing
Proper preparation, understanding how the medication works, and knowing what to expect can significantly ease your anxiety and set you up for success